MALVERN, Pa., July 10, 2019 /PRNewswire-PRWeb/ -- HMP, a leader in healthcare events and education, today announced the Community Oncology Alliance (COA) as an official partner of the Oncology Clinical Pathways Congress, taking place October 11-13, 2019 in Boston.
Launched in 2016, the Congress is the official meeting of the Journal of Clinical Pathways and focuses on the expansion of clinical pathways as a decision support tool and their increasing influence on patient care. The three-day meeting serves as a forum for stakeholders from all stages of the pathway process to ask questions, discuss best practices for measurement of outcomes, and explore new technologies, partnerships and expansion of pathway programs. Frederick M. Schnell, MD, FACP, chief medical officer of COA, serves as a Steering Committee member for the Congress and an editorial board member for the Journal of Clinical Pathways.
The 2019 Congress will delve into three key topic areas:
- Implementation: Develop a successful, evidence-based pathways program that delivers optimal patient care.
- Protocols: Understand the high-efficiency procedures that align payer, provider, and pathway needs.
- Compliance: Learn proven policies that protect and prevent obstacles for any pathway program.
"We are honored to partner with the Community Oncology Alliance," said Randy Robbin, president, NACCME, the medical education subsidiary of HMP. "This partnership is a reflection of the importance the meeting places on the role clinical pathways can play in providing affordable cancer care, especially in local communities. COA's long-standing leadership in patient advocacy and oncology practice makes this particularly noteworthy."
Participants of the 2019 meeting will also network with experts via case-based activities, roundtable discussions, and networking receptions.
To learn more about the meeting, visit clinicalpathwayscongress.oncnet.com.
ABOUT HMP
HMP is the force behind Healthcare Made Practical – and is a multichannel leader in health care events and education, with a mission to improve patient care. The company produces accredited medical education events and clinically relevant, evidence-based content for the global health care community across a range of therapeutic areas. Its brands include Consultant360, the year-round, award-winning platform relied upon by primary care providers and other specialists; Psych Congress, the largest independent mental health meeting in the U.S.; EMS World Expo, the largest EMS-dedicated event in the world; Rx Drug Abuse & Heroin Summit, the nation's leading meeting focused on addressing the opioid abuse epidemic; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com.
SOURCE HMP
Share this article